Delivery Order SPE2DB20D1109-SPE2DB24FP84H
Award Date
9/4/24
Potential Completion Date
9/5/24
Potential Value
$2.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 36 mg methylphenidate extended-release tablets, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has a firm fixed price of $1,614.66 and a completion date of May 21, 2025. The contract is not set aside for any specific business type....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,867.90 firm-fixed-price delivery order is for the supply of 100 tablets of 18 mg Methylphenidate Extended Release, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of May 7, 2025. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,025.46 firm fixed-price delivery order is for the supply of 100 count tablets of 27 mg methylphenidate extended-release, a medication commonly used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of May 9, 2024. AmerisourceBergen holds a $999,999,999...
This contract was awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of Methylphenidate extended-release 27 mg tablets, a medication commonly used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has a ceiling value of $1,037.76 and a completion date of April 29, 2024. It is a delivery order contract with a firm fixed...
This federal contract award, valued at $2,282.57, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 54mg methylphenidate extended-release tablets, a medication commonly used to treat attention-deficit/hyperactivity disorder (ADHD). The contract is structured as a delivery order and is priced on a firm-fixed-price basis. It does not have...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,213.23 firm fixed-price contract is for the delivery of 100 tablets of 27 mg extended-release methylphenidate, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of November 28, 2023. Amerisourcebergen holds a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,583 contract is for the supply of 100 tablets of Methylphenidate ER 18 mg, a medication used to treat attention deficit hyperactivity disorder (ADHD). The contract has an ultimate completion date of May 9, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This federal contract award, valued at $2,845.35, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 100 tablets of 36 mg Methylphenidate Extended Release, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract is a Firm Fixed Price Delivery Order with a completion date of February 5, 2025. The award is not associated with a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 54mg methylphenidate extended-release tablets. The contract has a ceiling value of $4,189.21 and a period of performance through April 18, 2025. It is a firm-fixed-price, non-set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
This federal contract award, issued by the Defense Logistics Agency (DLA), was granted to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,638.54 firm fixed-price delivery order is for the supply of 100 tablets of 18 mg Methylphenidate Extended Release, a medication commonly used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of March 10, 2025 and was awarded on March 7, 2025....